{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T12:10:24Z","timestamp":1660479024193},"reference-count":19,"publisher":"Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,2]]},"DOI":"10.14745\/ccdr.v43i02a01","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T14:32:21Z","timestamp":1518705141000},"page":"33-37","source":"Crossref","is-referenced-by-count":2,"title":["What are Canadian primary care physicians prescribing for the treatment of gonorrhea?"],"prefix":"10.14745","volume":"43","author":[{"given":"S","family":"Ha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Pogany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Gale-Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5795","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"issue":"6","key":"key20180215093205_r1","first-page":"642","volume":"85","year":"2012","journal-title":"Am Fam Physician."},{"issue":"10","key":"key20180215093205_r2","first-page":"1779","article-title":"Diagnosis and treatment of Nessieria gonorrhoeae infections.","volume":"73","year":"2006","journal-title":"Am Fam Physician."},{"issue":"2","key":"key20180215093205_r3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.14745\/ccdr.v41i02a02","article-title":"Gonorrhea in Canada: 2003 \u2013 2012.","volume":"41","year":"2015","journal-title":"Can Commun Dis Rep."},{"issue":"11","key":"key20180215093205_r4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.14745\/ccdr.v42i11a02","article-title":"Antimicrobial use and antimicrobial resistance trends in Canada: 2014.","volume":"42","year":"2016","journal-title":"Can Commun Dis Rep."},{"issue":"2","key":"key20180215093205_r5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14745\/ccdr.v41i02a04","article-title":"Antimicrobial resistance to Neisseria gonorrhoeae in Canada: 2009\u20132013.","volume":"41","year":"2015","journal-title":"Can Commun Dis Rep."},{"key":"key20180215093205_r6","unstructured":"Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections - Gonococcal Infections Chapter [Internet]. Ottawa: PHAC; 2013 [updated 2014 Sep 26; cited 2016 May 3]. Available from: http:\/\/www.phac-aspc.gc.ca\/std-mts\/sti-its\/cgsti-ldcits\/section-5-6-eng.php."},{"issue":"10","key":"key20180215093205_r7","first-page":"869","article-title":"Management of gonococcal infection among adults and youth.","volume":"61","year":"2015","journal-title":"Can Fam Physician."},{"issue":"31","key":"key20180215093205_r8","first-page":"590","article-title":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"6","key":"key20180215093205_r9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s10156-013-0597-6","article-title":"In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae.","volume":"19","year":"2013","journal-title":"J Infect Chemother."},{"issue":"1","key":"key20180215093205_r10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/OLQ.0b013e31827bd64c","article-title":"Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.","volume":"40","year":"2013","journal-title":"Sex Transm Dis."},{"issue":"3","key":"key20180215093205_r11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/jac\/dks449","article-title":"Combination therapy for gonorrhoea: In vitro synergy testing.","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother."},{"issue":"7","key":"key20180215093205_r12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/OLQ.0b013e3182941325","article-title":"Retreatment rates for uncomplicated gonorrhea infection: comparing ceftriaxone and azithromycin versus ceftriaxone and doxycycline.","volume":"40","year":"2013","journal-title":"Sex Transm Dis."},{"issue":"6","key":"key20180215093205_r13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/OLQ.0000000000000280","article-title":"Gonorrhea treatment failures with oral and injectable expanded spectrum cephalosporin monotherapy vs. dual therapy at 4 Canadian sexually transmitted infection clinics, 2010-2013.","volume":"42","year":"2015","journal-title":"Sex Transm Dis."},{"key":"key20180215093205_r14","doi-asserted-by":"crossref","unstructured":"Gratrix J, Bergman J, Anderson N, Read R, Singh A, Smyczek P [Internet]. Adherence to new treatment guidelines for uncomplicated anogenital and pharyngeal Neisseria Gonorrhea cases in adults in Alberta, Canada. Meeting of the Infectious Diseases Society of America. 2014 [cited 2016 Dec 24]. Available from: https:\/\/www.researchgate.net\/publication\/267881937_Adherence_to_New_Treatment_Guidelines_for_Uncomplicated_Anogenital_and_Pharyngeal_Neisseria_Gonorrhea_Cases_in_Adults_in_Alberta_Canada.","DOI":"10.1093\/ofid\/ofu052.1299"},{"issue":"5","key":"key20180215093205_r15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/OLQ.0000000000000113","article-title":"Variation in adherence to the treatment guidelines for Neisseria gonorrhoeae by clinical practice setting, California, 2009 to 2011.","volume":"41","year":"2014","journal-title":"Sex Transm Dis."},{"key":"key20180215093205_r16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/sti.2010.042317","article-title":"The Eastern European Sexual and Reproductive Health (EE SRH) Network Antimicrobial Resistance Group. Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial.","volume":"86","year":"2010","journal-title":"Sex Transm Infect."},{"issue":"1","key":"key20180215093205_r17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/OLQ.0000000000000217","article-title":"Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012.","volume":"42","year":"2015","journal-title":"Sex Transm Dis."},{"issue":"5","key":"key20180215093205_r18","first-page":"1","article-title":"Diagnosis and treatment of chlamydia and gonorrhoea in general practice in England 2000-2011: a population-based study using data from the UK clinical practice research datalink.","volume":"5","year":"2015","journal-title":"BMJ Open."},{"issue":"2","key":"key20180215093205_r19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.","volume":"309","year":"2013","journal-title":"JAMA"}],"container-title":["Canada Communicable Disease Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/17vol43\/dr-rm43-2\/assets\/pdf\/17vol43_2-ar-01-eng.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T11:38:24Z","timestamp":1660477104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/17vol43\/dr-rm43-2\/assets\/pdf\/17vol43_2-ar-01-eng.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,2]]},"published-print":{"date-parts":[[2017,2,2]]}},"URL":"https:\/\/doi.org\/10.14745\/ccdr.v43i02a01","relation":{},"ISSN":["1481-8531"],"issn-type":[{"value":"1481-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}